Template:Oroboros MitoFit box: Difference between revisions
From Bioblast
Laner Verena (talk | contribs) No edit summary |
Laner Verena (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
<div style="font-size:100%;font-weight:bold;padding:0.2em;padding-right: 0.4em;padding-left: 0.4em;background-color:#eeeeee;border-bottom:1px solid #aaaaaa;text-align:left;"> | <div style="font-size:100%;font-weight:bold;padding:0.2em;padding-right: 0.4em;padding-left: 0.4em;background-color:#eeeeee;border-bottom:1px solid #aaaaaa;text-align:left;"> | ||
[[Image:Logo MitoFit.jpg|120px|right|link=http://www.mitofit.org/index.php/MitoFit|MitoFit]] | [[Image:Logo MitoFit.jpg|120px|right|link=http://www.mitofit.org/index.php/MitoFit|MitoFit]] | ||
[[ | [[OROBOROS_Contact#Project_overview|'''OROBOROS projects''']] | ||
</div> | </div> | ||
<div style="background-color:#ffffff;padding-top:0.2em;padding-right: 0.4em;padding-bottom: 0.2em;padding-left: 0.4em;"> | <div style="background-color:#ffffff;padding-top:0.2em;padding-right: 0.4em;padding-bottom: 0.2em;padding-left: 0.4em;"> |
Revision as of 17:53, 9 March 2017
- OROBOROS INSTRUMENTS participates in two HORIZON 2020 funded Marie Skłodowska-Curie projects:
- TRANSMIT- TRANSlating the role of MItochondria in Tumorigenesis: Open PhD position available. More details?
- TRACT – Training in Cancer mechanisms and Therapeutics: PhD network focussed on the three critical areas: biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms in oral and oesophageal cancer. More details?
- Horizon 2020 COST Action CA15203 MITOEAGLE - More details?